NCT03978793View on ClinicalTrials.gov

MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

March 12, 2025

Study Completion Date

April 30, 2025

Conditions
HIV-positive Individuals
Interventions
DEVICE

MyTPill, a digital pill

MyTPill is a digital pill containing an approved medication

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
collaborator

University of Miami

OTHER

collaborator

The Miriam Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Florida International University

OTHER

lead

Ohio State University

OTHER

NCT03978793 - MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users | Biotech Hunter | Biotech Hunter